These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2150077)

  • 1. Single photon emission computed tomography in subjects at risk for Huntington's chorea.
    Leblhuber F; Brucker B; Reisecker F; Steinparz F; Windhager E; Trenkler J; Deisenhammer E
    J Neurol; 1990 Dec; 237(8):496-8. PubMed ID: 2150077
    [No Abstract]   [Full Text] [Related]  

  • 2. Single photon emission computed tomography in Huntington's chorea.
    Leblhuber F; Hoell K; Reisecker F; Gebetsberger B; Puehringer W; Trenkler E; Deisenhammer E
    Psychiatry Res; 1989 Sep; 29(3):337-9. PubMed ID: 2532751
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional caudate imaging in symptomatic Huntington's disease: positron emission tomography versus single-photon emission computed tomography.
    Martin WR; Hoskinson M; Kremer B; Maguire C; McEwan A
    J Neuroimaging; 1995 Oct; 5(4):227-32. PubMed ID: 7579751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [SPECT studies with 99mTc-HMPAO in Huntington's chorea patients].
    Botsch H; Oepen G; Deuschl G; Wolff G
    Rofo; 1987 Dec; 147(6):666-8. PubMed ID: 2827263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography.
    Reid IC; Besson JA; Best PV; Sharp PF; Gemmell HG; Smith FW
    J Neurol Neurosurg Psychiatry; 1988 Oct; 51(10):1264-8. PubMed ID: 2976081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrophy of caudate nucleus in Huntington's disease measured by computed tomography.
    Roth J; Havrdová E; Růzicka E
    J Neurol; 2000 Nov; 247(11):880-1. PubMed ID: 11151423
    [No Abstract]   [Full Text] [Related]  

  • 7. Single photon emission computed tomographic blood flow and magnetic resonance volume imaging of basal ganglia in Huntington's disease.
    Harris GJ; Aylward EH; Peyser CE; Pearlson GD; Brandt J; Roberts-Twillie JV; Barta PE; Folstein SE
    Arch Neurol; 1996 Apr; 53(4):316-24. PubMed ID: 8929153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathologic correlation of computerized tomography in Huntington's disease.
    Terrence CF; Rao G
    South Med J; 1980 Jun; 73(6):817-8. PubMed ID: 6446759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of caudate nucleus area--a more accurate measurement for Huntington's disease?
    Wardlaw JM; Sellar RJ; Abernethy LJ
    Neuroradiology; 1991; 33(4):316-9. PubMed ID: 1833664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT brainstem abnormalities in the differential diagnosis of Huntington's disease.
    Masucci EF; Borts FT; Kurtzke JF
    Comput Med Imaging Graph; 1990; 14(3):205-12. PubMed ID: 2140710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease?
    Lang C
    Neuroradiology; 1985; 27(2):161-3. PubMed ID: 3157882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
    Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased iodine-123 IMP caudate nucleus uptake in patients with Huntington's disease.
    Nagel JS; Johnson KA; Ichise M; English RJ; Walshe TM; Morris JH; Holman BL
    Clin Nucl Med; 1988 Jul; 13(7):486-90. PubMed ID: 2971497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebellum and brain stem atrophy in a child with Huntington's chorea.
    Hattori H; Takao T; Ito M; Nakano S; Okuno T; Mikawa H
    Comput Radiol; 1984; 8(1):53-6. PubMed ID: 6230208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumoencephalographic findings in Huntington's chorea.
    Gath I; Vinje B
    Neurology; 1968 Oct; 18(10):991-6. PubMed ID: 4235183
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered patterns of regional cerebral blood flow in patients with Huntington's disease: a SPECT study during rest and cognitive or motor activation.
    Deckel AW; Weiner R; Szigeti D; Clark V; Vento J
    J Nucl Med; 2000 May; 41(5):773-80. PubMed ID: 10809191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography in the early diagnosis of Huntington's disease.
    Hayden MR; Martin WR; Stoessl AJ; Clark C; Hollenberg S; Adam MJ; Ammann W; Harrop R; Rogers J; Ruth T
    Neurology; 1986 Jul; 36(7):888-94. PubMed ID: 2940474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral glucose consumption measured by PET in patients with and without psychiatric symptoms of Huntington's disease.
    Kuwert T; Lange HW; Langen KJ; Herzog H; Aulich A; Feinendegen LE
    Psychiatry Res; 1989 Sep; 29(3):361-2. PubMed ID: 2532753
    [No Abstract]   [Full Text] [Related]  

  • 20. Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography.
    Künig G; Leenders KL; Sanchez-Pernaute R; Antonini A; Vontobel P; Verhagen A; Günther I
    Ann Neurol; 2000 May; 47(5):644-8. PubMed ID: 10805336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.